住院COVID-19患者危重症发生风险临床评分工具的开发与验证
该研究与中国国家卫生健康委员会合作,建立截至2020年1月31日来自31个省级行政区575家医院的COVID-19回顾性队列,用LASSO和logistic回归从72个候选预测因子中筛选出10个独立预测因子构建COVID-GRAM评分,用于估计住院COVID-19患者发生危重症的风险。开发队列1590例,平均年龄48.9岁,男性904例(57.3%);验证队列710例,平均年龄48.2岁,男性382例(53.8%)。开发队列平均AUC为0.88(95%CI 0.85-0.91),验证队列AUC为0.88(95%CI 0.84-0.93)。评分已转化为免费在线风险计算器。
要点
- 危重症定义为入住ICU、有创通气或死亡的复合终点,评分在入院时即可计算。
- 10个预测因子包括胸部影像学异常(OR 3.39)、年龄(OR 1.03)、咯血(OR 4.53)、呼吸困难(OR 1.88)、意识不清(OR 4.71)、合并症数量(OR 1.60)、肿瘤病史(OR 4.07)、中性粒细胞与淋巴细胞比值(OR 1.06)、乳酸脱氢酶(OR 1.002)、直接胆红素(OR 1.15)。
- 开发队列平均AUC 0.88(95%CI 0.85-0.91),验证队列AUC 0.88(95%CI 0.84-0.93)。
- 评分已转化为免费在线风险计算器(http://118.126.104.170/)。
适用人群与场景
- 住院的COVID-19患者,数据来自中国575家医院31个省级行政区,截至2020年1月31日。
诊断标准与关键阈值
- 危重症定义为入住ICU、有创通气或死亡的复合终点。
研究设计与关键结果
- 回顾性队列研究,开发队列1590例,平均年龄48.9(15.7)岁,男性904例(57.3%);验证队列710例,平均年龄48.2(15.2)岁,男性382例(53.8%)。
- 从72个候选预测因子中筛选出10个独立预测因子构建COVID-GRAM评分:胸部影像学异常(OR 3.39;95%CI 2.14-5.38)、年龄(OR 1.03;95%CI 1.01-1.05)、咯血(OR 4.53;95%CI 1.36-15.15)、呼吸困难(OR 1.88;95%CI 1.18-3.01)、意识不清(OR 4.71;95%CI 1.39-15.98)、合并症数量(OR 1.60;95%CI 1.27-2.00)、肿瘤病史(OR 4.07;95%CI 1.23-13.43)、中性粒细胞与淋巴细胞比值(OR 1.06;95%CI 1.02-1.10)、乳酸脱氢酶(OR 1.002;95%CI 1.001-1.004)、直接胆红素(OR 1.15;95%CI 1.06-1.24)。
- 开发队列平均AUC为0.88(95%CI 0.85-0.91),验证队列AUC为0.88(95%CI 0.84-0.93)。
证据类型、等级与局限
- 证据类型:回顾性队列研究(开发与验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于入院时特征的评分可能有助于预测COVID-19患者发生危重症的风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Early identification of patients with novel coronavirus disease 2019 (COVID-19) who may develop critical illness is of great importance and may aid in delivering proper treatment and optimizing use of resources.
OBJECTIVE: To develop and validate a clinical score at hospital admission for predicting which patients with COVID-19 will develop critical illness based on a nationwide cohort in China.
DESIGN, SETTING, AND PARTICIPANTS: Collaborating with the National Health Commission of China, we established a retrospective cohort of patients with COVID-19 from 575 hospitals in 31 provincial administrative regions as of January 31, 2020. Epidemiological, clinical, laboratory, and imaging variables ascertained at hospital admission were screened using Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression to construct a predictive risk score (COVID-GRAM). The score provides an estimate of the risk that a hospitalized patient with COVID-19 will develop critical illness. Accuracy of the score was measured by the area under the receiver operating characteristic curve (AUC). Data from 4 additional cohorts in China hospitalized with COVID-19 were used to validate the score. Data were analyzed between February 20, 2020 and March 17, 2020.
MAIN OUTCOMES AND MEASURES: Among patients with COVID-19 admitted to the hospital, critical illness was defined as the composite measure of admission to the intensive care unit, invasive ventilation, or death.
RESULTS: The development cohort included 1590 patients. the mean (SD) age of patients in the cohort was 48.9 (15.7) years; 904 (57.3%) were men. The validation cohort included 710 patients with a mean (SD) age of 48.2 (15.2) years, and 382 (53.8%) were men and 172 (24.2%). From 72 potential predictors, 10 variables were independent predictive factors and were included in the risk score: chest radiographic abnormality (OR, 3.39; 95% CI, 2.14-5.38), age (OR, 1.03; 95% CI, 1.01-1.05), hemoptysis (OR, 4.53; 95% CI, 1.36-15.15), dyspnea (OR, 1.88; 95% CI, 1.18-3.01), unconsciousness (OR, 4.71; 95% CI, 1.39-15.98), number of comorbidities (OR, 1.60; 95% CI, 1.27-2.00), cancer history (OR, 4.07; 95% CI, 1.23-13.43), neutrophil-to-lymphocyte ratio (OR, 1.06; 95% CI, 1.02-1.10), lactate dehydrogenase (OR, 1.002; 95% CI, 1.001-1.004) and direct bilirubin (OR, 1.15; 95% CI, 1.06-1.24). The mean AUC in the development cohort was 0.88 (95% CI, 0.85-0.91) and the AUC in the validation cohort was 0.88 (95% CI, 0.84-0.93). The score has been translated into an online risk calculator that is freely available to the public (http://118.126.104.170/).
CONCLUSIONS AND RELEVANCE: In this study, a risk score based on characteristics of COVID-19 patients at the time of admission to the hospital was developed that may help predict a patient's risk of developing critical illness.
参考来源
- Liang W, Liang H, Ou L, et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020. PMID: 32396163. doi:10.1001/jamainternmed.2020.2033
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。